Artel Acquires Software to Expand its Liquid Handler Performance Verification Capabilities
News Jan 27, 2014
The software will be used with Artel’s MVS® Multichannel Verification System to deliver increased information availability and management.
The prototype technology was described in an article, “High-Throughput Quality Control of DMSO Acoustic Dispensing Using Photometric Dye Methods,” published in the Journal of Laboratory Automation (JALA) in July of 2013.
The new software capabilities, which will also be integrated into Artel’s Liquid Handling Performance Verification Service, will enable customers to track and manage the performance of their automated liquid handlers over time by aggregating the standardized measurements from the MVS.
The software is built on StackWave’s proprietary application development platform. As part of the acquisition agreement, Ryan Meyer, one of StackWave’s principals, will join Artel in the position of software architect to facilitate further enhancements to the product.
“StackWave has a unique understanding of what our MVS and service customers need to manage their volume verification data and to extract valuable information from it,” explains Kirby Pilcher, Artel CEO. “Artel and StackWave have shared a vision of giving our laboratory customers improved insight into the quality and accuracy of their tools and processes.”
Artel previewed its new ArtelWare product, based on the acquired LabGauge technology, at SLAS 2014 and expects to begin shipping around the end of the first quarter.
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Deceased Data: Should Your Online Remains Be Treated Like Physical Remains?News
In 2018, your death doesn't just leave behind a body. It leaves behind a huge online footprint - your digital remains. A new study asks whether these remains should be treated and respected as a corpse would, and whether museums may provide a blueprint for the preservation process.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018